Depo-Provera Meningioma Lawsuit in Arkansas
Last Updated: April 1, 2026
Arkansas provides a relatively generous three-year statute of limitations for both personal injury and product liability claims, giving residents more time to pursue Depo-Provera and GLP-1 medication injury cases. The state's two federal judicial districts cover its diverse landscape from the Delta region to the Ozark highlands. Arkansas also recognizes the discovery rule, which can further extend filing deadlines when injuries from pharmaceutical products are not immediately apparent.
Depo-Provera (medroxyprogesterone acetate) has been linked to meningioma brain tumors. The FDA added a black-box warning in December 2025, and over 3,000 lawsuits have been filed nationwide. Arkansas residents who used Depo-Provera and were diagnosed with a meningioma may qualify for compensation. The statute of limitations in Arkansas for personal injury claims is 3 years. Attorneys handle these cases on a contingency fee basis — no cost unless you win.
Depo-Provera Meningioma Claims in Arkansas
Depo-Provera (medroxyprogesterone acetate) has been linked to meningioma brain tumors. The FDA added a black-box warning in December 2025, and over 3,000 lawsuits have been filed nationwide. Arkansas residents who used Depo-Provera and were diagnosed with a meningioma may qualify for compensation on a contingency fee basis — no cost unless you win.
In December 2025, the FDA took the significant step of updating Depo-Provera's label to include a formal warning about the elevated risk of meningioma associated with prolonged use. This label change came after years of accumulating scientific evidence — including studies from France and other countries — demonstrating a clear dose-response relationship between medroxyprogesterone acetate and meningioma development.
For Arkansas residents who used Depo-Provera and were subsequently diagnosed with a meningioma, the legal landscape is now clear: the manufacturer knew or should have known about this risk and failed to provide adequate warnings. Over 3,000 lawsuits have been filed across the country, and Arkansas residents are actively filing claims to seek compensation for their injuries.
Meningiomas, while often classified as benign tumors, can cause devastating symptoms including chronic headaches, seizures, vision and hearing problems, cognitive impairment, and personality changes. Treatment frequently requires invasive brain surgery, radiation therapy, or both. Many patients face recurring tumors and lifelong monitoring.
Arkansas legal landscape: Arkansas follows modified comparative fault with a 49% bar — a plaintiff who is 50% or more at fault cannot recover. The state applies strict liability for product defect claims and does not impose statutory caps on punitive damages in pharmaceutical cases. Residents in Little Rock, Fort Smith, Fayetteville, and Springdale and surrounding areas should consult with an attorney experienced in pharmaceutical litigation to evaluate their potential claim.
Arkansas Statute of Limitations
Understanding the statute of limitations is critical for Arkansas residents considering a Depo-Provera meningioma lawsuit. In Arkansas, the statute of limitations for personal injury claims is 3 years. For product liability claims specifically, the deadline is 3 years.
Arkansas recognizes the discovery rule, which is particularly important in pharmaceutical injury cases. Under this rule, the statute of limitations may begin running not from the date of your last Depo-Provera injection, but from the date you discovered — or reasonably should have discovered — the connection between Depo-Provera and your meningioma. Given that the FDA only formally warned about this risk in December 2025, many Arkansas residents may still be within their filing window even if their diagnosis occurred years ago.
Do not assume your deadline has passed without consulting an attorney. The interplay between personal injury and product liability statutes, the discovery rule, and the facts of your specific case can create nuances that only a qualified legal professional can properly evaluate.
Personal Injury SOL
3 years
Product Liability SOL
3 years
Discovery Rule
Yes
How to File a Depo-Provera Lawsuit in Arkansas
Filing a Depo-Provera meningioma lawsuit in Arkansas involves several steps, but the process begins with a simple, no-cost case evaluation. Here is what to expect:
Free Case Review
Complete a free case evaluation to determine whether your Depo-Provera usage and meningioma diagnosis qualify for legal action under Arkansas law.
Attorney Referral
If your case qualifies, you will be connected with experienced mass tort attorneys licensed to practice in Arkansas who specialize in pharmaceutical litigation.
Case Filing
Your attorney will file your claim in the appropriate court. In Arkansas, cases may be filed in the Arkansas Circuit Courts or in federal court (Eastern District of Arkansas and other federal districts).
Litigation & Resolution
Your legal team handles all proceedings including discovery, depositions, and trial preparation. You pay nothing unless you receive compensation through settlement or verdict.
Do You Qualify in Arkansas?
Arkansas residents may be eligible to file a Depo-Provera meningioma claim if the following criteria are met:
Used Depo-Provera Injections
You received one or more Depo-Provera (medroxyprogesterone acetate) injections while residing in Arkansas or another state.
Diagnosed with a Meningioma
You have been diagnosed with a meningioma brain tumor, confirmed through imaging (MRI or CT scan) or surgical pathology.
Timeline Consistent with Causation
Your meningioma diagnosis occurred after you began receiving Depo-Provera injections, establishing a timeline that supports a causal connection.
Within the Filing Deadline
Your claim falls within Arkansas's statute of limitations (3 years for personal injury). The discovery rule may extend this deadline — an attorney can evaluate your specific timeline.
Arkansas Depo-Provera FAQ
What is a meningioma and how is it linked to Depo-Provera in Arkansas?
A meningioma is a tumor that forms on the membranes covering the brain and spinal cord. In December 2025, the FDA updated Depo-Provera's label to warn about the increased risk of meningioma brain tumors. Arkansas residents who used Depo-Provera and were later diagnosed with a meningioma may be eligible to file a claim. Multiple studies have shown that prolonged use of medroxyprogesterone acetate, the active ingredient in Depo-Provera, is associated with a significantly elevated risk of developing meningiomas.
What is the statute of limitations for a Depo-Provera lawsuit in Arkansas?
In Arkansas, the statute of limitations for personal injury claims is 3 years from the date of injury or discovery. Arkansas recognizes the discovery rule, which means the clock may start when you discovered — or reasonably should have discovered — the connection between Depo-Provera and your meningioma, rather than the date of your last injection. Because these deadlines are strict and missing them can permanently bar your claim, prompt action is critical.
How do I file a Depo-Provera meningioma lawsuit in Arkansas?
Filing a Depo-Provera meningioma lawsuit in Arkansas begins with a free case review to determine your eligibility. If your case qualifies, you will be connected with experienced mass tort attorneys who can file your claim in either the Arkansas Circuit Courts or the appropriate federal district court. Most cases are being consolidated in federal multidistrict litigation (MDL) for efficiency. Your attorney handles all legal filings and proceedings on your behalf.
What compensation is available for Arkansas Depo-Provera victims?
Arkansas residents who qualify may be entitled to compensation for medical expenses (surgery, radiation, imaging, hospital stays, and ongoing monitoring), lost wages and diminished earning capacity, pain and suffering, and emotional distress. The amount of compensation depends on the severity of your meningioma, the treatment required, and the impact on your daily life and ability to work.
Which courts handle Depo-Provera cases in Arkansas?
Depo-Provera meningioma cases in Arkansas can be filed in the Arkansas Circuit Courts at the state level or in federal court. The federal districts covering Arkansas include the Eastern District of Arkansas, Western District of Arkansas. Many cases are being consolidated in a federal multidistrict litigation (MDL) for pretrial proceedings, with individual cases returning to their home districts for trial if needed.
Does it cost anything to file a Depo-Provera claim in Arkansas?
There is no upfront cost to file a Depo-Provera meningioma claim in Arkansas. Attorneys handling these cases work on a contingency fee basis, meaning they only receive payment if you obtain compensation through a settlement or trial verdict. NuLegal's initial case review is completely free with no obligation to proceed.
Related Resources
Arkansas Residents: Don't Wait
The statute of limitations in Arkansas is 3 years for personal injury claims. Get a free, no-obligation case review today to find out if you qualify for compensation.
Free Case ReviewAdvertisement
Disclosure: NuLegal operates as a legal referral service. Attorney Ashkaan Hassan evaluates claims and refers qualified cases to specialized trial firms, earning a referral fee from the attorney's share of any recovery. Clients never pay out of pocket.